Discontinued — last reported Q1 '24
Medtronic Middle East Africa Latin America Eastern Europeand Asia Excluding Japanand Korea — Net Sales increased by 5.2% to $1.57B in Q1 2024 compared to the prior quarter. Year-over-year, this metric grew by 9.2%, from $1.44B to $1.57B. Over 3 years (FY 2021 to FY 2024), Middle East Africa Latin America Eastern Europeand Asia Excluding Japanand Korea — Net Sales shows an upward trend with a 6.8% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates successful market penetration and growing demand for medical technology in developing regions, while a decrease may signal competitive pressure or economic headwinds in those territories.
This metric represents the total revenue generated from the sale of medical devices and therapeutic solutions within des...
Peers in the medical device sector typically report this as 'International' or 'Emerging Markets' revenue, with growth rates often benchmarked against regional GDP and healthcare spending trends.
mdt_segment_emerging_markets_net_sales| Q1 '21 | Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.34B | $1.29B | $1.37B | $1.39B | $1.38B | $1.28B | $1.36B | $1.37B | $1.44B | $1.31B | $1.44B | $1.50B | $1.57B |
| QoQ Change | — | -3.7% | +6.7% | +0.9% | -0.1% | -7.7% | +6.5% | +0.9% | +5.0% | -8.8% | +9.7% | +3.7% | +5.2% |
| YoY Change | — | — | — | — | +3.6% | -0.8% | -0.9% | -1.0% | +4.1% | +3.0% | +6.0% | +9.0% | +9.2% |